Phibro Animal Health Corporation (NASDAQ:PAHC) VP Daniel M. Bendheim sold 300 shares of the firm’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $40.08, for a total transaction of $12,024.00. Following the completion of the sale, the vice president now owns 300 shares in the company, valued at approximately $12,024. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded up 0.50% during trading on Wednesday, hitting $40.00. 55,178 shares of the stock were exchanged. The stock’s 50 day moving average price is $38.23 and its 200 day moving average price is $32.54. The firm has a market capitalization of $1.59 billion, a price-to-earnings ratio of 24.84 and a beta of 1.35. Phibro Animal Health Corporation has a 52 week low of $20.14 and a 52 week high of $40.25.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be issued a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a dividend yield of 1.00%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio is currently 24.69%.

ILLEGAL ACTIVITY NOTICE: This story was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.watchlistnews.com/phibro-animal-health-corporation-pahc-vp-daniel-m-bendheim-sells-300-shares/1496803.html.

Institutional investors have recently added to or reduced their stakes in the stock. Chicago Equity Partners LLC acquired a new position in Phibro Animal Health Corporation during the first quarter valued at approximately $376,000. Great West Life Assurance Co. Can raised its position in Phibro Animal Health Corporation by 7.3% in the first quarter. Great West Life Assurance Co. Can now owns 26,554 shares of the company’s stock valued at $745,000 after buying an additional 1,802 shares in the last quarter. Wells Fargo & Company MN raised its position in Phibro Animal Health Corporation by 0.7% in the first quarter. Wells Fargo & Company MN now owns 125,941 shares of the company’s stock valued at $3,540,000 after buying an additional 932 shares in the last quarter. Russell Investments Group Ltd. acquired a new position in Phibro Animal Health Corporation during the first quarter valued at approximately $748,000. Finally, Sit Investment Associates Inc. acquired a new position in Phibro Animal Health Corporation during the first quarter valued at approximately $2,037,000. 47.64% of the stock is currently owned by institutional investors.

A number of analysts have weighed in on the stock. Credit Suisse Group lowered shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their target price for the company from $29.00 to $36.00 in a research report on Friday, June 2nd. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Finally, Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research report on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $30.50.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.